LeBron James at 40: A milestone birthday arrives Monday for the NBA's all-time scoring leader When LeBron James broke another NBA record earlier this month, the one for most regular-season minutes played in a career, his Los Angeles Lakers teammates handled the moment in typical locker room fashion. They made fun of him. Dubbed The Kid from Akron, with a limitless future, James is now the 40-year-old from Los Angeles with wisps of gray in his beard, his milestone birthday coming Monday, one that will make him the first player in NBA history to play in his teens, 20s, 30s and 40s. He has stood and excelled in the spotlight his entire career. 'Sonic 3' and 'Mufasa' battle for No. 1 at the holiday box office Two family films are dominating the holiday box office, with “Sonic the Hedgehog 3” winning the three-day weekend over “Mufasa” by a blue hair. According to studio estimates Sunday, the Sonic movie earned $38 million, while “Mufasa” brought in $37.1 million from theaters in the U.S. and Canada. The R-rated horror “Nosferatu” placed third with an unexpectedly strong $21.2 million. Thanksgiving release holdovers “Wicked” and “Moana 2” rounded out the top five. Christmas Day had several big film openings, including the Bob Dylan biopic “A Complete Unknown,” the Nicole Kidman erotic drama “Babygirl” and the boxing drama “The Fire Inside.” Belgium will ban sales of disposable e-cigarettes in a first for the EU BRUSSELS (AP) — Belgium will ban the sale of disposable electronic cigarettes as of Jan. 1 on health and environmental grounds in a groundbreaking move for European Union nations. Health minister Frank Vandenbroucke tells The Associated Press that the inexpensive e-cigarettes have turned into a health threat since they are an easy way for teenagers to be drawn into smoking and get hooked on nicotine. Australia outlawed the sale of “vapes” outside pharmacies earlier this year in some of the world’s toughest restrictions on electronic cigarettes. Now Belgium is leading the EU drive. Belgium's minister wants tougher tobacco measures in the 27-nation bloc. Charles Dolan, HBO and Cablevision founder, dies at 98 Charles F. Dolan, who founded some of the most prominent U.S. media companies including Home Box Office Inc. and Cablevision Systems Corp., has died at age 98. Newsday reports that a statement issued Saturday by his family says Dolan died of natural causes. Dolan’s legacy in cable broadcasting includes founding HBO in 1972, Cablevision in 1973 and the American Movie Classics television station in 1984. He also launched News 12 in New York City, the first U.S. 24-hour cable channel for local news. Dolan also held controlling stakes in companies that owned Madison Square Garden, Radio City Music Hall, the New York Knicks and the New York Rangers. Snoop's game: Snoop Dogg thrills the crowd in the bowl that bears his name TUCSON, Ariz. (AP) — Miami of Ohio beat Colorado State in the Arizona Bowl, but Snoop Dogg was the main attraction. The Snoop Dogg Arizona Bowl presented by Gin & Juice by Dre and Snoop was much a spectacle as a football game. Snoop Dogg seemed to be everywhere all at once, from a pregame tailgate to the postgame trophy presentation. Snoop Dog donned a headset on Colorado State's sideline, spent some time in the broadcast and even led both marching bands as conductor during their halftime performance. Snoop Dogg saved the best for last, rolling out in a light green, lowrider Chevy Impala with gold rims and accents, the shiny Arizona Bowl trophy in his hand as fans screamed his name. Mavs star Luka Doncic is latest pro athlete whose home was burglarized, business manager says DALLAS (AP) — Luka Doncic of the Dallas Mavericks is the latest professional athlete whose home has been burglarized. The star guard’s business manager tells multiple media outlets there was a break-in at Doncic’s home Friday night. Lara Beth Seager says nobody was home, and Doncic filed a police report. The Dallas Morning News reports that jewelry valued at about $30,000 was stolen. Doncic is the sixth known pro athlete in the U.S. whose home was burglarized since October. Star NFL quarterbacks Patrick Mahomes of Kansas City and Joe Burrow of Cincinnati are among them. The NFL and NBA have issued security alerts to players over the break-ins. Victor Wembanyama plays 1-on-1 chess with fans in New York Victor Wembanyama went to a park in New York City and played 1-on-1 with fans on Saturday. He even lost a couple of games. Not in basketball, though. Wemby was playing chess. Before the San Antonio Spurs left New York for a flight to Minnesota, Wembanyama put out the call on social media: “Who wants to meet me at the SW corner of Washington Square park to play chess? Im there,” Wembanyama wrote. It was 9:36 a.m. And people began showing up almost immediately. Norwegian chess grandmaster Magnus Carlsen quits a tournament in a dispute over jeans NEW YORK (AP) — The International Chess Federation says top ranked player Magnus Carlsen has left the World Rapid and Blitz Chess Championships after refusing to change out of the jeans he wore to the competition. The federation said Friday that its regulations include a dress code that bars participants from wearing jeans at the event. The Norwegian chess grandmaster says he accepted a $200 fine but refused to change his pants out of principle before leaving the competition in New York. The federation said the dress code is designed to ensure professionalism and fairness for all participants. Trailblazing model Dayle Haddon dies from suspected carbon monoxide poisoning NEW HOPE, Pa. (AP) — A trailblazing former “Sports Illustrated” model who pushed back against age discrimination has died in a Pennsylvania home from what authorities believe was carbon monoxide poisoning. Authorities in Bucks County found 76-year-old Dayle Haddon, dead in a second-floor bedroom Friday morning after emergency dispatchers were notified about a person unconscious at the Solebury Township home. A 76-year-old man who was also in the home was hospitalized in critical condition. As a model, Haddon appeared on dozens of magazine coverage in the 1970s and 1980s. She then reentered the industry in the 1990s after landing contracts with cosmetic companies to promote their anti-aging products. 2 Oregon men die from exposure in a forest after they went out to look for Sasquatch STEVENSON, Wash. (AP) — Officials say two Oregon men have died in a Washington state forest after they failed to return from a trip to look for Sasquatch. The Skamania County Sheriff’s Office says the 59-year-old and 37-year-old appear to have died from exposure. The sheriff's office says it based that conclusion on the weather and their lack of preparedness. Both men were from Portland. They were found in a heavily wooded area of the Gifford Pinchot National Forest northeast of that city. Family reported them missing after they failed to return from a Christmas Eve outing. Sasquatch is a folkloric beast thought by some to roam the forests, particularly in the Pacific Northwest.
Firan Technology Group Corporation Completes Acquisition of FLYHT Aerospace Solutions Ltd.Nokia Corporation Stock Exchange Release 27 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 27.12.2024 Espoo, Finland - On 27 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia's Annual General Meeting on 3 April 2024 started on 25 November 2024 and end by 31 December 2025 and target to repurchase 150 million shares for a maximum aggregate purchase price of EUR 900 million. Total cost of transactions executed on 27 December 2024 was EUR 3,740,926. After the disclosed transactions, Nokia Corporation holds 220,370,243 treasury shares. Details of transactions are included as an appendix to this announcement. On behalf of Nokia Corporation BofA Securities Europe SA About Nokia At Nokia, we create technology that helps the world act together. As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs. With truly open architectures that seamlessly integrate into any ecosystem, our high-performance networks create new opportunities for monetization and scale. Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today - and work with us to create the digital services and applications of the future. Inquiries: Nokia Communications Phone: +358 10 448 4900 Email: [email protected] Maria Vaismaa, Global Head of External Communications Nokia Investor Relations Phone: +358 40 803 4080 Email: [email protected] Attachment Daily Report 2024-12-27
( MENAFN - financial News Media) FN media Group Presents USA News Group News Commentary Vancouver, BC – December 20, 2024 – USA News Group – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights , underscoring major strides in cancer research and ongoing innovation. However, the optimism is tempered by a troubling finding: a significant global rise in early-onset colorectal cancer cases . This unsettling trend comes as the medical community grapples with the lingering effects of the COVID-19 pandemic. A recent Nature article revealed how disruptions in cancer care-particularly delays in screenings, diagnoses, and treatments-have likely exacerbated the progression of advanced disease, diminished survival rates, and complicated long-term data analysis. Still, the oncology field continues to push forward with promising developments emerging from key innovators like O ncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Cardiff Oncology, Inc. (NASDAQ: CRDF), Personalis, Inc. (NASDAQ: PSNL), Tempus AI, Inc. (NASDAQ: TEM), and Checkpoint Therapeutics, Inc. (NASDAQ: CKPT). The article continued: Additionally, the American Cancer Society has spotlighted an alarming rise in cancer incidence and mortality among younger age groups. Analysts at Exactitude Consultancy anticipate that the global Cancer Immunotherapy Market will expand at a robust 12.84% CAGR, reaching $258.22 billion by 2031 -a clear indicator of oncology's rapid growth and critical importance. Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) , a leading clinical-stage company specializing in immunotherapy for oncology, today announced the presentation of two data sets through two abstracts showcasing pelareorep's potential in difficult-to-treat gastrointestinal cancers, which were accepted and will be presented at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco January 23-25, 2025. “We are enthusiastic about pelareorep's applicability across multiple gastrointestinal cancer indications, including pancreatic and anal cancer,” said Tom Heineman, M.D., Ph.D., Chief Medical Officer of Oncolytics .“Pelareorep engages patients' immune systems to help make commonly used chemotherapies and checkpoint inhibitors, such as atezolizumab, more effective in fighting cancer. This offers the promise of delaying disease progression and improving survival in patients with these devasting diseases. Given the versatility of pelareorep, we see multiple clinical and regulatory options for bringing this promising medicine to patients.” Oncolytics will present two key data sets from the GOBLET study, with preliminary safety and tumor response results for the relapsed anal carcinoma cohort treated with pelareorep and atezolizumab presented in Poster Session C on January 25, 2025, from 7:00 to 7:55 a.m. PT. Additionally, results from the safety run-in phase for first-line metastatic pancreatic ductal adenocarcinoma patients treated with pelareorep, modified FOLFIRINOX, with and without atezolizumab will be presented in Poster Session B on January 24, 2025, from 11:30 a.m. to 1:00 p.m. PT. Both abstracts will be available on the ASCO Gastrointestinal Cancers Symposium website at 5:00 p.m. ET on January 21, 2025. CONTINUED... Read this and more news for Oncolytics Biotech at: In other recent industry developments and happenings in the market include: Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently announced positive initial data from CRDF-004, a randomized, Phase 2 clinical trial evaluating onvansertib in combination with standard-of-care (SoC) in patients with first-line RAS-mutated metastatic colorectal cancer (mCRC). Efficacy and safety data are for all evaluable patients as of a November 26, 2024, data cut-off date, and all efficacy data are determined by a blinded, independent central review (BICR) of each patient's tumor scan. “We are highly encouraged by the robust efficacy signal and favorable safety profile observed with onvansertib plus standard-of-care from the first 30 evaluable patients in our randomized first-line RAS-mutated mCRC CRDF-004 trial,” said Fairooz Kabbinavar, MD, FACP, Chief Medical Officer of Cardiff Oncology .“Our data shows an objective response rate of 64% in patients receiving the 30 mg dose of onvansertib in combination with standard of care, significantly higher than the 33% objective response rate observed in the control arms of standard of care alone. In addition, as can be seen in the spider plots, we are observing deeper tumor response in patients receiving the 30mg dose of onvansertib compared to those receiving the 20mg dose with similar safety profiles for both doses.” Personalis, Inc. (NASDAQ: PSNL), a developer of advanced cancer genomic tests and analytics, and Tempus AI, Inc. (NASDAQ: TEM), an AI-powered healthcare technology company, recently announced they've expanded their commercial relationship. Both companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus is serving as the exclusive commercial diagnostic partner for Personalis' ultra-sensitive tumor-informed MRD product, NeXT Personal® Dx, for broad patient adoption in breast and lung cancers, and for immunotherapy monitoring across all solid tumors. “While we already offer NeXT Personal through our own biopharma channel, we are pleased to leverage Tempus' integrated platform as well for these biopharma customers who desire to combine NeXT Personal with other Tempus products,” said Chris Hall, CEO of Personalis .“We believe the expansion of the relationship with Tempus will accelerate market penetration of our leading ultra-sensitive MRD platform and allow us to better capitalize on the opportunity.” Under this expanded relationship, Tempus will be enabled to offer Personalis' NeXT Personal MRD product to pharmaceutical and biotech customers who wish to bundle MRD testing with other Tempus offerings in a given study. Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), a commercial-stage immunotherapy and targeted oncology company focused on novel treatments for patients with solid tumor cancers, recently announced that the FDA approved its UNLOXCYTTM (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. UNLOXCYT is the first and only programmed death ligand-1 (PD-L1) blocking antibody to receive FDA marketing approval for this indication. “[This] FDA approval of UNLOXCYT – the first marketing approval for our company – is a significant milestone both for Checkpoint and for patients with advanced cSCC,” said James Oliviero, President and CEO of Checkpoin t.“This approval marks Checkpoint's transformation to a commercial-stage company, with the opportunity to compete in a U.S. market estimated to exceed $1 billion annually, where we believe UNLOXCYT offers a differentiated treatment option versus available therapies by binding to PD-L1, rather than programmed death receptor-1 (PD-1), to release the inhibitory effects of PD-L1 on the anti-tumor immune response. Additionally, UNLOXCYT has demonstrated the ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC), another potential differentiating feature of the drug compared to existing marketed therapies for patients with cSCC.” Source: CONTACT: USA NEWS GROUP ... (604) 265-2873 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Oncolytics Biotech Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares of Oncolytics Biotech Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Oncolytics Biotech Inc. which were purchased in the open market, and reserve the right to buy and sell, and will buy and sell shares of Oncolytics Biotech Inc. at any time without any further notice commencing immediately and ongoing. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by Oncolytics Biotech Inc.; this is a paid advertisement, we currently own shares of Oncolytics Biotech Inc. and will buy and sell shares of the company in the open market, or through private placements, and/or other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. USA News Group is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with USA News Group or any company mentioned herein. The commentary, views and opinions expressed in this release by USA News Group are solely those of USA News Group and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release. This release contains“forward-loking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.“Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as“may”,“future”,“plan” or“planned”,“will” or“should”,“expected,”“anticipates”,“draft”,“eventually” or“projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements. Media Contact Information: FN Media Group, LLC Media Contact e-mail: ... U.S. Phone: +1(954)345-0611 SOURCE USA News Group MENAFN20122024000225011067ID1109018678 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.Angela Poundmaker-Gromova, in Halifax on Nov. 25, was able to secure a higher paying job after took a course in growth marketing, a field that uses data analysis to drive customer acquisition and retention. Darren Calabrese/The Globe and Mail By age 36, when Angela Poundmaker-Gromova finished her communications degree, she had already worked in hairstyling, hospitality, film and television. In her new career, she found herself stuck in a series of entry-level jobs at a stage in her life when she had more work experience and better soft skills than her peers, and more training on new technologies than her superiors. She also felt underpaid. To secure a higher-paying role, Ms. Poundmaker-Gromova took a course in growth marketing, a field that uses data analysis to drive customer acquisition and retention. In addition to those skills, the course taught her how to prepare for an interview and negotiate salary, and how to retool her LinkedIn profile to best position her for the types of jobs she wanted. She was recruited shortly afterward and got a new marketing industry job. She now makes significantly more than in her last position and has a much better work environment. “It was life-changing,” said Ms. Poundmaker-Gromova, now 38 and a resident of Halifax. After years of steep inflation and high interest rates, many Canadians are looking for ways to increase their salaries to catch up with the higher cost of living. In a recent report by human resources firm Robert Half, 92 per cent of Canadian workers said they are concerned about inflation outpacing salary growth, with 51 per cent saying they feel underpaid. The company’s survey of 1,750 workers aged 18 and up, conducted in June for its 2025 Canadian Salary Guide , found pay is the top thing workers are looking for in a new job. But given that it’s also a time of weak employment growth, is now a good time to try to find a new job – or to ask for a raise? Experts suggest starting by figuring out how your salary compares with that of others who do similar work, and finding ways to expand your value as a worker, whether through adding new skills or overperforming in your role. Jodi Kovitz, chief executive officer of the Ontario-based Human Resources Professional Association, said her organization’s members are fielding raise requests often these days. “Salary concerns driven by inflation are totally prominent,” said Ms. Kovitz, while adding the uncertain economy has made it challenging for some companies to offer raises across the board, and so are choosing to focus instead on rewarding top performers. “We’re seeing more targeted salary adjustments.” It’s important for those who plan to advocate for a raise to make sure they can show the value they bring to the organization, she said. If someone arrives at a meeting with their manager ready to describe how they’ve gone beyond expectations, and has done market research that shows people in similar roles are getting paid more at other companies, their chances of success are higher, she said. Ms. Kovitz also suggests using such a conversation as a way to plot out a future path at the company. “You can say to your manager, ‘I would really like to stay here, and here’s why,’” she said. “As a leader, I am much more inclined to want to invest in, from an energy and development perspective, into someone I see as a potential successor to someone who is a leader on my team.” Jermaine L. Murray, a recruiter and career coach, said this meeting can be a place for the employee and manager to agree on the worker’s strengths and weaknesses, and set milestones for the next six months. “Once this meeting concludes, send a follow-up email as both a thank-you and a confirmation of what took place,” advised Mr. Murray, founder of Toronto-based JupiterHR. “Then focus on knocking each milestone out of the park over the next six months. Two weeks before the six-month mark, schedule a follow-up meeting to go over the milestones and to get feedback on your performance. If done correctly, you’ll have buy-in from your manager who will advocate for you to get a raise.” Mr. Murray also encourages workers to apply for jobs if they feel underpaid, if only to get a sense for what they could make elsewhere. But he cautions that changing jobs involves risk, and should be done with careful consideration. “If you accept a new job without doing your due diligence because you’re desperate for change, the chances of it backfiring rise significantly,” he said. Sarah Stockdale – the chief executive officer of Growclass, the growth marketing training company whose course helped Ms. Poundmaker-Gromova get a higher-paying job – said targeted upskilling can help someone change companies, or earn more where they currently work. “You can start by looking around and seeing who has the job that you want, and what are the skills they bring,” said Ms. Stockdale, who is based in Toronto. She notes that skills related to artificial intelligence can increase one’s salary significantly. PwC’s 2024 AI Jobs Barometer report found jobs that require “specialist AI skills” carry up to a 25-per-cent wage premium over similar positions that don’t require use of AI, and give workers a much stronger bargain position. Ms. Stockdale said many tech workers who were laid off in recent years took the first job they could get after their layoff, and are now feeling “underpaid and undervalued,” especially in cases where workers with the same job titles aren’t being paid the same amount because some were hired in stronger economic times. “That can stir up a lot of anger and resentment,” she said, and encourages those in this position to approach the issue by seeking to understand the situation, rather than being confrontational. “Compensation discrepancies aren’t always intentional. “You want to be on the same team: You and your manager versus the problem that possibly there’s a gap in your compensation,” she said. Are you a young Canadian with money on your mind? To set yourself up for success and steer clear of costly mistakes, listen to our award-winning Stress Test podcast .
PlayersTV Acquires Cloud Media Center, Integrates Sports-AI Ad Technology to Surpass 1B Monthly ImpressionsWhite House says at least 8 US telecom firms, dozens of nations impacted by China hacking campaign
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Northwest Bancorp - FNWBGainers Lytus Technologies Hldgs LYT shares moved upwards by 181.6% to $2.83 during Friday's pre-market session. The company's market cap stands at $5.2 million. Baosheng Media Gr BAOS stock increased by 9.67% to $1.7. The company's market cap stands at $2.6 million. LQR House YHC stock rose 6.91% to $1.7. The company's market cap stands at $12.1 million. Asset Entities ASST shares moved upwards by 6.71% to $0.41. The company's market cap stands at $2.4 million. TuanChe TC stock moved upwards by 6.65% to $1.0. The company's market cap stands at $1.7 million. Losers FingerMotion FNGR stock fell 25.0% to $1.5 during Friday's pre-market session. The market value of their outstanding shares is at $80.7 million. Ucloudlink Group UCL stock fell 12.12% to $1.85. The company's market cap stands at $69.1 million. Scholastic SCHL shares declined by 11.4% to $22.01. The market value of their outstanding shares is at $619.3 million. As per the press release, Q2 earnings came out yesterday. Haoxi Health Technology HAO shares declined by 10.85% to $0.11. The market value of their outstanding shares is at $5.3 million. MultiMetaVerse Holdings MMV shares decreased by 8.57% to $0.57. The market value of their outstanding shares is at $21.2 million. Kuke Music Hldg KUKE shares decreased by 7.7% to $0.36. The company's market cap stands at $14.2 million. See Also: www.benzinga.com/money/best-communication-services-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
LeBron James at 40: A milestone birthday arrives Monday for the NBA's all-time scoring leader When LeBron James broke another NBA record earlier this month, the one for most regular-season minutes played in a career, his Los Angeles Lakers teammates handled the moment in typical locker room fashion. They made fun of him. Dubbed The Kid from Akron, with a limitless future, James is now the 40-year-old from Los Angeles with wisps of gray in his beard, his milestone birthday coming Monday, one that will make him the first player in NBA history to play in his teens, 20s, 30s and 40s. He has stood and excelled in the spotlight his entire career. 'Sonic 3' and 'Mufasa' battle for No. 1 at the holiday box office Two family films are dominating the holiday box office, with “Sonic the Hedgehog 3” winning the three-day weekend over “Mufasa” by a blue hair. According to studio estimates Sunday, the Sonic movie earned $38 million, while “Mufasa” brought in $37.1 million from theaters in the U.S. and Canada. The R-rated horror “Nosferatu” placed third with an unexpectedly strong $21.2 million. Thanksgiving release holdovers “Wicked” and “Moana 2” rounded out the top five. Christmas Day had several big film openings, including the Bob Dylan biopic “A Complete Unknown,” the Nicole Kidman erotic drama “Babygirl” and the boxing drama “The Fire Inside.” Belgium will ban sales of disposable e-cigarettes in a first for the EU BRUSSELS (AP) — Belgium will ban the sale of disposable electronic cigarettes as of Jan. 1 on health and environmental grounds in a groundbreaking move for European Union nations. Health minister Frank Vandenbroucke tells The Associated Press that the inexpensive e-cigarettes have turned into a health threat since they are an easy way for teenagers to be drawn into smoking and get hooked on nicotine. Australia outlawed the sale of “vapes” outside pharmacies earlier this year in some of the world’s toughest restrictions on electronic cigarettes. Now Belgium is leading the EU drive. Belgium's minister wants tougher tobacco measures in the 27-nation bloc. Charles Dolan, HBO and Cablevision founder, dies at 98 Charles F. Dolan, who founded some of the most prominent U.S. media companies including Home Box Office Inc. and Cablevision Systems Corp., has died at age 98. Newsday reports that a statement issued Saturday by his family says Dolan died of natural causes. Dolan’s legacy in cable broadcasting includes founding HBO in 1972, Cablevision in 1973 and the American Movie Classics television station in 1984. He also launched News 12 in New York City, the first U.S. 24-hour cable channel for local news. Dolan also held controlling stakes in companies that owned Madison Square Garden, Radio City Music Hall, the New York Knicks and the New York Rangers. Snoop's game: Snoop Dogg thrills the crowd in the bowl that bears his name TUCSON, Ariz. (AP) — Miami of Ohio beat Colorado State in the Arizona Bowl, but Snoop Dogg was the main attraction. The Snoop Dogg Arizona Bowl presented by Gin & Juice by Dre and Snoop was much a spectacle as a football game. Snoop Dogg seemed to be everywhere all at once, from a pregame tailgate to the postgame trophy presentation. Snoop Dog donned a headset on Colorado State's sideline, spent some time in the broadcast and even led both marching bands as conductor during their halftime performance. Snoop Dogg saved the best for last, rolling out in a light green, lowrider Chevy Impala with gold rims and accents, the shiny Arizona Bowl trophy in his hand as fans screamed his name. Mavs star Luka Doncic is latest pro athlete whose home was burglarized, business manager says DALLAS (AP) — Luka Doncic of the Dallas Mavericks is the latest professional athlete whose home has been burglarized. The star guard’s business manager tells multiple media outlets there was a break-in at Doncic’s home Friday night. Lara Beth Seager says nobody was home, and Doncic filed a police report. The Dallas Morning News reports that jewelry valued at about $30,000 was stolen. Doncic is the sixth known pro athlete in the U.S. whose home was burglarized since October. Star NFL quarterbacks Patrick Mahomes of Kansas City and Joe Burrow of Cincinnati are among them. The NFL and NBA have issued security alerts to players over the break-ins. Victor Wembanyama plays 1-on-1 chess with fans in New York Victor Wembanyama went to a park in New York City and played 1-on-1 with fans on Saturday. He even lost a couple of games. Not in basketball, though. Wemby was playing chess. Before the San Antonio Spurs left New York for a flight to Minnesota, Wembanyama put out the call on social media: “Who wants to meet me at the SW corner of Washington Square park to play chess? Im there,” Wembanyama wrote. It was 9:36 a.m. And people began showing up almost immediately. Norwegian chess grandmaster Magnus Carlsen quits a tournament in a dispute over jeans NEW YORK (AP) — The International Chess Federation says top ranked player Magnus Carlsen has left the World Rapid and Blitz Chess Championships after refusing to change out of the jeans he wore to the competition. The federation said Friday that its regulations include a dress code that bars participants from wearing jeans at the event. The Norwegian chess grandmaster says he accepted a $200 fine but refused to change his pants out of principle before leaving the competition in New York. The federation said the dress code is designed to ensure professionalism and fairness for all participants. Trailblazing model Dayle Haddon dies from suspected carbon monoxide poisoning NEW HOPE, Pa. (AP) — A trailblazing former “Sports Illustrated” model who pushed back against age discrimination has died in a Pennsylvania home from what authorities believe was carbon monoxide poisoning. Authorities in Bucks County found 76-year-old Dayle Haddon, dead in a second-floor bedroom Friday morning after emergency dispatchers were notified about a person unconscious at the Solebury Township home. A 76-year-old man who was also in the home was hospitalized in critical condition. As a model, Haddon appeared on dozens of magazine coverage in the 1970s and 1980s. She then reentered the industry in the 1990s after landing contracts with cosmetic companies to promote their anti-aging products. 2 Oregon men die from exposure in a forest after they went out to look for Sasquatch STEVENSON, Wash. (AP) — Officials say two Oregon men have died in a Washington state forest after they failed to return from a trip to look for Sasquatch. The Skamania County Sheriff’s Office says the 59-year-old and 37-year-old appear to have died from exposure. The sheriff's office says it based that conclusion on the weather and their lack of preparedness. Both men were from Portland. They were found in a heavily wooded area of the Gifford Pinchot National Forest northeast of that city. Family reported them missing after they failed to return from a Christmas Eve outing. Sasquatch is a folkloric beast thought by some to roam the forests, particularly in the Pacific Northwest.Liverpool boss Arne Slot hailed “special” Mohamed Salah after seeing him fire the Premier League leaders to the brink of victory at Newcastle. The Reds ultimately left St James’ Park with only a point after Fabian Schar snatched a 3-3 draw at the end of a pulsating encounter, but Salah’s double – his 14th and 15th goals of the season – transformed a 2-1 deficit into a 3-2 lead before the Switzerland defender’s late intervention. The 32-year-old Egypt international’s future at Anfield remains a topic of debate with his current contract running down. Asked about Salah’s future, Slot said: “It’s difficult for me to predict the long-term future, but the only thing I can expect or predict is that he is in a very good place at the moment. Two goals and an assist for Mo tonight 👏 pic.twitter.com/tMXidgeA0P — Liverpool FC (@LFC) December 4, 2024 “He plays in a very good team that provides him with good opportunities and then he is able to do special things. “And what makes him for me even more special is that in the first hour or before we scored to make it 1-1, you thought, ‘He’s not playing his best game today’, and to then come up with a half-hour or 45 minutes – I don’t know how long it was – afterwards with an assist, two goals, having a shot on the bar, being a constant threat, that is something not many players can do if they’ve played the first hour like he did. “That is also what makes him special. If you just look at the goals, his finish is so clinical. He’s a special player, but that’s what we all know.” Salah did indeed endure a quiet opening 45 minutes by his standards and it was the Magpies who went in at the break a goal to the good after Alexander Isak’s stunning 35th-minute finish. Slot said: “The shot from Isak, I don’t even know if Caoimh (keeper Caoimhin Kelleher) saw that ball, as hard as it was.” Salah set up Curtis Jones to level five minutes into the second half and after Anthony Gordon has restored the hosts’ lead, levelled himself from substitute Trent Alexander-Arnold’s 68th-minute cross. He looked to have won it with a fine turn and finish – his ninth goal in seven league games – seven minutes from time, only for Schar to pounce from a tight angle in the 90th minute. Newcastle head coach Eddie Howe was delighted with the way his team took the game to the Reds four days after their disappointing 1-1 draw at Crystal Palace. Howe, who admitted his surprise that VAR official Stuart Attwell had not taken a dimmer view of a Virgil van Dijk shoulder barge on Gordon, said: “It’s mixed emotions. “Part of me feels we should have won it – a big part of me – but part of me is pleased we didn’t lose either because it was such a late goal for us. “Generally, I’m just pleased with the performance. There was much more attacking output, a much better feel about the team. “There was much better energy, and it was a really good performance against, for me, the best team we’ve played so far this season in the Premier League, so it was a big jump forward for us.”